SEARCH

SEARCH BY CITATION

References

  • Abdulla F. A., Bradbury E., Calaminici M. R., Lippiello P. M., Wonnacott S., Gray J. a. and Sinden J. D. (1996) Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology (Berl) 124, 323331.
  • Albuquerque E. X., Pereira E. F. R., Alkondon M. and Rogers S. W. (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73120.
  • Benquet P., Gee C. E. and Gerber U. (2002) Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. J. Neurosci. 22, 96799686.
  • Bitner R. S., Bunnelle W. H., Anderson D. J. et al. (2007) Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J. Neurosci. 27, 1057810587.
  • Briggs C. A., McKenna D. G. and Piattoni-Kaplan M. (1995) Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 34, 583590.
  • Briggs C. A., Anderson D. J., Brioni J. D., et al. (1997) Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol. Biochem. Behav. 57, 231241.
  • Buccafusco J. J., Letchworth S. R., Bencherif M. and Lippiello P. M. (2005) Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol. Sci. 26, 352360.
  • Chernyavsky A. I., Arredondo J., Qian J., Galitovskiy V. and Grando Sa. (2009) Coupling of ionic events to protein kinase signaling cascades upon activation of alpha7 nicotinic receptor: cooperative regulation of alpha2-integrin expression and Rho kinase activity. J. Biol. Chem. 284, 2214022148.
  • Chernyavsky A. I., Arredondo J., Galitovskiy V., Qian J. and Grando Sa. (2010) Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases. Am. J. Physiol. Cell Physiol. 299, C903C911.
  • Christensen D. Z., Mikkelsen J. D., Hansen H. H. and Thomsen M. S. (2010) Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain. J. Neurochem. 114, 12051216.
  • Christianson J. C. and Green W. N. (2004) Regulation of nicotinic receptor expression by the ubiquitin-proteasome system. EMBO J. 23, 41564165.
  • Dani Ja. and Bertrand D. (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47, 699729.
  • Dinklo T., Shaban H., Thuring J. W. et al. (2011) Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 336, 560574.
  • Dunlop J., Lock T., Jow B. et al. (2009) Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b’]di pyrrole-1(2H)-carboxamide). J. Pharmacol. Exp. Ther. 328, 766776.
  • Fabian-Fine R., Skehel P., Errington M. L., Davies Ha., Sher E., Stewart M. G. and Fine a. (2001) Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 21, 79938003.
  • Faghih R., Gopalakrishnan M. and Briggs C. A. (2008) Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. J. Med. Chem. 51, 701712.
  • Fenster C. P., Whitworth T. L., Sheffield E. B., Quick M. W. and Lester Ra. (1999) Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J. Neurosci. 19, 48044814.
  • Freedman R., Olincy A., Buchanan R. W. et al. (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am. J. Psychiatry 165, 10401047.
  • Gotti C., Moretti M., Maggi R., Longhi R., Hanke W., Klinke N. and Clementi F. (1997) Alpha7 and alpha8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci. 9, 12011211.
  • Govind A. P., Vezina P. and Green W. N. (2009) Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem. Pharmacol. 78, 756765.
  • Grønlien J. H., Håkerud M., Ween H., Thorin-Hagene K., Briggs C. A., Gopalakrishnan M. and Malysz J. (2007) Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol. Pharmacol. 72, 715724.
  • Hajos M. (2009) Targeting a7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia. Curr. Pharm. Des. 999, 117.
  • Haustein K.-O. and Groneberg D.. (2009) Tobacco Or Health? Physiological and Social Damages Caused by Tobacco Smoking. 2nd Edition, Springer, Berlin.
  • Hu M., Gopalakrishnan M. and Li J. (2009) Positive allosteric modulation of α7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons. Br. J. Pharmacol. 158, 18571864.
  • Hurst R. S., Hajós M., Raggenbass M. et al. (2005a) A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J. Neurosci. 25, 43964405.
  • Kawai H. and Berg D. K. (2001) Nicotinic acetylcholine receptors containing alpha 7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure. J. Neurochem. 78, 13671378.
  • Kitagawa H., Takenouchi T., Azuma R., Wesnes Ka., Kramer W. G., Clody D. E. and Burnett A. L. (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28, 542551.
  • Kuryatov A., Luo J., Cooper J. and Lindstrom J. (2005) Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol. Pharmacol. 68, 18391851.
  • Lester H. A., Xiao C., Srinivasan R., Son C. D., Miwa J., Pantoja R., Banghart M. R., Dougherty Da., Goate A. M. and Wang J. C. (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J. 11, 167177.
  • Marks M. J., Stitzel J. A. and Collins A. C. (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol. Exp. Ther. 235, 619628.
  • Marks M. J., Romm E., Gaffney D. K. and Collins A. C. (1986a) (a) Nicotine-induced tolerance and receptor changes in four mouse strains. J. Pharmacol. Exp. Ther. 237, 809819.
  • Marks M. J., Stitzel J. A., Romm E., Wehner J. M. and Collins A. C. (1986b) (b) Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol. Pharmacol. 30, 427436.
  • Marks M. J., McClure-Begley T. D., Whiteaker P., Salminen O., Brown R. W. B., Cooper J., Collins A. C. and Lindstrom J. M. (2011) Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J. Pharmacol. Exp. Ther. 337, 187200.
  • Matta S. G. et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190, 269319.
  • McLean S. L., Idris N., Grayson B., Gendle D., Mackie C., Lesage A., Pemberton D. J. and Neill J.. (2011) PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. J. Psychopharmacol. in press.
  • Mielke J. G. and Mealing G. a. R. (2009) Cellular distribution of the nicotinic acetylcholine receptor alpha7 subunit in rat hippocampus. Neurosci. Res. 65, 296306.
  • Molinari E. J., Delbono O., Messi M. L., Renganathan M., Arneric S. P., Sullivan J. P. and Gopalakrishnan M. (1998) Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur. J. Pharmacol. 347, 131139.
  • Moretti M., Mugnaini M., Tessari M., Zoli M., Gaimarri A., Manfredi I., Pistillo F., Clementi F. and Gotti C. (2010) A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol. Pharmacol. 78, 287296.
  • Murray T. A., Liu Q., Whiteaker P., Wu J. and Lukas R. J. (2009) Nicotinic acetylcholine receptor alpha7 subunits with a C2 cytoplasmic loop yellow fluorescent protein insertion form functional receptors. Acta Pharmacol. Sin. 30, 828841.
  • Ng H. J., Whittemore E. R., Tran M. B., Hogenkamp D. J., Broide R. S., Johnstone T. B., Zheng L., Stevens K. E. and Gee K. W. (2007) Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc. Natl Acad. Sci. USA 104, 80598064.
  • Olincy A., Harris J. G., Johnson L. L. et al. (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch. Gen. Psychiatry 63, 630638.
  • Paxinos G. and Watson C. (1986) The rat brain in stereotaxic coordinates. Academic Press, London.
  • Peng X., Gerzanich V., Anand R., Whiting P. J. and Lindstrom J. (1994a) (a) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46, 523530.
  • Peng X., Katz M., Gerzanich V., Anand R. and Lindstrom J. (1994b) (b) Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 45, 546554.
  • Peng J. H., Lucero L., Fryer J., Herl J., Leonard S. S. and Lukas R. J. (1999) Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line. Brain Res. 825, 172179.
  • Rasmussen B. A. and Perry D. C. (2006) An autoradiographic analysis of [125I]alpha-bungarotoxin binding in rat brain after chronic nicotine exposure. Neurosci. Lett. 404, 914.
  • Rezvani K., Teng Y., Shim D. and Biasi M De. (2007) Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J. Neurosci. 27, 1050810519.
  • Ridley D. L., Rogers A. and Wonnacott S. (2001) Differential effects of chronic drug treatment on a3 * and a7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Br. J. Pharmacol. 133, 12861295.
  • Thomsen M. S. and Mikkelsen J. D.. (2012) The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets? Curr. Drug Targets. 13, 707720.
  • Thomsen M. S., Hansen H. H., Timmermann D. B. and Mikkelsen J. D. (2010) Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr. Pharm. Des. 16, 323343.
  • Tietje K. R. et al. (2008) Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties. CNS Neurosci. Ther. 14, 6582.
  • Timmermann D. B., Grønlien J. H., Kohlhaas K. L. et al. (2007) An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J. Pharmacol. Exp. Ther. 323, 294307.
  • Vallejo Y. F., Buisson B., Bertrand D. and Green W. N. (2005) Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25, 55635572.
  • Wallace T. L. and Porter R. H. P. (2011) Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem. Pharmacol. 82, 891903.
  • Werkheiser J. L., Sydserff S., Hubbs S. J., Ding M., Eisman M. S., Perry D., Williams a. J., Smith J. S., Mrzljak L. and Maier D. L. (2011) Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy. Neuroscience 186, 7687.
  • Williams D. K., Wang J. and Papke R. L.. (2011) Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem. Pharmacol. 82, 915930.
  • Zhong C., Du C., Hancock M., Mertz M., Talmage Da. and Role L. W. (2008) Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors. J. Neurosci. 28, 91119116.